The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of CLIA accredited multi-omic platforms to correlate clinical significance of WES/WTS testing with functional protein/phosphoprotein drug target activity.
 
Rachel Elsey
Consulting or Advisory Role - VieCure
Research Funding - Sema4 (Inst)
 
Tobias Meissner
Stock and Other Ownership Interests - Sema4
Research Funding - Cellworks (Inst); Sema4 (Inst)
 
Claudius Mueller
Employment - Theralink
Stock and Other Ownership Interests - Theralink
Patents, Royalties, Other Intellectual Property - Patent: Dynactin subunit p62 biomarker for neurological conditions. (US Patent 9,746,458; 08-29- 2017)
Travel, Accommodations, Expenses - Theralink
 
Brian Corgiat
Stock and Other Ownership Interests - Theralink
 
Justin B Davis
Employment - Theralink
Stock and Other Ownership Interests - Theralink
Travel, Accommodations, Expenses - Theralink
 
Crystal Hattum
Research Funding - Sema4
Travel, Accommodations, Expenses - Sema4
 
William Charles Spanos
Consulting or Advisory Role - Ambu; Bristol-Myers Squibb; Merck; Regeneron
Travel, Accommodations, Expenses - Ambu; NantWorks; Regeneron
 
David Starks
Research Funding - Takeda (Inst)
 
Benjamin Maurice Solomon
Consulting or Advisory Role - Bayer
Research Funding - AstraZeneca/Merck (Inst)
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera; Theralink
Consulting or Advisory Role - Ceres Nanosciences; Perthera; Theralink
Research Funding - Ceres Nanosciences (Inst); Deciphera; G1 Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); SpringWorks Therapeutics
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
John H. Lee
Leadership - Vincerx Pharma
 
Casey B. Williams
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Genentech (I); Sema4
Consulting or Advisory Role - Sema4; Takeda; VieCure
Research Funding - Kiadis Pharma (Inst); Sema4 (Inst); Takeda (Inst); Tesaro (Inst)